Autoimmune Syndromes Presenting as a Paraneoplastic Manifestation of Myelodysplastic Syndromes: Clinical Features, Course, Treatment and Outcome

por Williamson, Bradley T., Foltz, Lynda, Leitch, Heather A.
Publicado 2016

Clinical Features, Treatment, and Outcome of HIV-Associated Immune Thrombocytopenia in the HAART Era

por Ambler, Kimberley L. S., Vickars, Linda M., Leger, Chantal S., Foltz, Lynda M., Montaner, Julio S. G., Harris, Marianne, Dias Lima, Viviane, Leitch, Heather A.
Publicado 2012

Patterns of Ruxolitinib Therapy Failure and Its Management in Myelofibrosis: Perspectives of the Canadian Myeloproliferative Neoplasm Group

por Gupta, Vikas, Cerquozzi, Sonia, Foltz, Lynda, Hillis, Christopher, Devlin, Rebecca, Elsawy, Mahmoud, Grewal, Kuljit, Hamm, Caroline, McNamara, Caroline, Sirhan, Shireen, Leber, Brian
Publicado 2020

The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark survey

por Harrison, Claire N., Koschmieder, Steffen, Foltz, Lynda, Guglielmelli, Paola, Flindt, Tina, Koehler, Michael, Mathias, Jonathan, Komatsu, Norio, Boothroyd, Robert N., Spierer, Amber, Perez Ronco, Julian, Taylor-Stokes, Gavin, Waller, John, Mesa, Ruben A.
Publicado 2017

Comparing the safety and efficacy of ruxolitinib in patients with Dynamic International Prognostic Scoring System low‐, intermediate‐1‐, intermediate‐2‐, and high‐risk myelofibrosi...

por Passamonti, Francesco, Gupta, Vikas, Martino, Bruno, Foltz, Lynda, Zaritskey, Andrey, Al‐Ali, Haifa Kathrin, Tavares, Renato, Maffioli, Margherita, Raanani, Pia, Giraldo, Pilar, Griesshammer, Martin, Guglielmelli, Paola, Bouard, Catherine, Paley, Carole, Tiwari, Ranjan, Vannucchi, Alessandro M.
Publicado 2021

Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study

por Cervantes, Francisco, Ross, David M., Radinoff, Atanas, Palandri, Francesca, Myasnikov, Alexandr, Vannucchi, Alessandro M., Zachee, Pierre, Gisslinger, Heinz, Komatsu, Norio, Foltz, Lynda, Mannelli, Francesco, Passamonti, Francesco, Gilotti, Geralyn, Sadek, Islam, Tiwari, Ranjan, Zor, Evren, Al-Ali, Haifa Kathrin
Publicado 2021

Correction: Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study

por Cervantes, Francisco, Ross, David M., Radinoff, Atanas, Palandri, Francesca, Myasnikov, Alexandr, Vannucchi, Alessandro M., Zachee, Pierre, Gisslinger, Heinz, Komatsu, Norio, Foltz, Lynda, Mannelli, Francesco, Passamonti, Francesco, Gilotti, Geralyn, Sadek, Islam, Tiwari, Ranjan, Zor, Evren, Al-Ali, Haifa Kathrin
Publicado 2021

Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial

por Verstovsek, Srdan, Foltz, Lynda, Gupta, Vikas, Hasserjian, Robert, Manshouri, Taghi, Mascarenhas, John, Mesa, Ruben, Pozdnyakova, Olga, Ritchie, Ellen, Veletic, Ivo, Gamel, Katia, Hamidi, Habib, Han, Lyrialle, Higgins, Brian, Trunzer, Kerstin, Uguen, Marianne, Wang, Dao, El-Galaly, Tarec Christoffer, Todorov, Boyan, Gotlib, Jason
Publicado 2023

PB2681: GAPS IN THE ASSESSMENT AND MONITORING OF CARDIOVASCULAR RISK AND PSYCHOLOGICAL BURDEN IN POLYCYTHEMIA VERA: LANDMARK 2.0: A WORLDWIDE HEALTH SURVEY

por Harrison, Claire, Ross, David, Fogliatto, Laura, Foltz, Lynda, Busque, Lambert, Xiao, Zhijian, Heidel, Florian, Koehler, Michael, Palumbo, Giuseppe A., Breccia, Massimo, Komatsu, Norio, Kirito, Keita, Cirici, Blanca Xicoy, Martinez-Lopez, Joaquín, Rovó, Alicia, Petruk, Cheryl, Bobirca, Catalin, Mirams, Laura, Mcmillan, Abigail, Harper, Gavin, Kiladjian, Jean-Jacques
Publicado 2023

Symptomatic benefit of momelotinib in patients with myelofibrosis: Results from the SIMPLIFY phase III studies

por Mesa, Ruben A., Hudgens, Stacie, Floden, Lysbeth, Harrison, Claire N., Palmer, Jeanne, Gupta, Vikas, McLornan, Donal P., McMullin, Mary F., Kiladjian, Jean‐Jaques, Foltz, Lynda, Platzbecker, Uwe, Fox, M. Laura, Mead, Adam J., Ross, David M., Oh, Stephen T., Perkins, Andrew, Leahy, Michael F., Deheshi, Samineh, Donahue, Rafe, Klencke, Barbara J., Verstovsek, Srdan
Publicado 2023

Patient-reported Outcomes and Quality of Life in Anemic and Symptomatic Patients With Myelofibrosis: Results From the MOMENTUM Study

por Mesa, Ruben A., Harrison, Claire, Palmer, Jeanne M., Gupta, Vikas, McLornan, Donal P., McMullin, Mary Frances, Kiladjian, Jean-Jacques, Foltz, Lynda, Platzbecker, Uwe, Fox, Maria Laura, Mead, Adam J., Ross, David M., Oh, Stephen T., Perkins, Andrew Charles, Leahy, Michael F., Kawashima, Jun, Ro, Sunhee, Donahue, Rafe, Gorsh, Boris, Deheshi, Samineh, Verstovsek, Srdan
Publicado 2023